Heart bypass drug combo trial pulled before it even started
NCT ID NCT06730945
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 17 times
Summary
This study aimed to see if taking two blood-pressure medicines (isosorbide mononitrate and amlodipine) for 24 weeks after heart bypass surgery could prevent the radial artery graft from failing. It planned to enroll adults who had just received a radial artery graft during bypass. However, the trial was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, China
Conditions
Explore the condition pages connected to this study.